Literature DB >> 25747012

Hemichorea in a diabetes mellitus patient following acute ischemic stroke with changes in regional cerebral blood flow.

Yutaka Suzuki1, Minoru Oishi2, Akira Kanno2, Katsuhiko Ogawa2, Mariko Fujisawa2, Satoshi Kamei2.   

Abstract

It is not unusual to observe hemichorea in patients with diabetes mellitus, with origins attributable to recent ischemia. Our patient was a 66-year-old female with diabetes mellitus who suddenly developed right hemichorea, mild muscle weakness of the right upper extremity, ideational apraxia, and acalculia. Her blood glucose was 600 mg/dL, and HbA1c was 13.3%. After the patient underwent head magnetic resonance imaging (MRI), a new cerebral infarction was observed in the left frontal lobe, and treatment was started with edaravone and cilostazol. At the same time, insulin treatment was also started for hyperglycemia. The acalculia and ideational apraxia improved approximately 1 week after treatment initiated, and the hemichorea also decreased. ECD-SPECT was performed on admission, and it was observed that blood flow was decreased in the left frontal lobe and striatum, but increased in the thalamus; two weeks later on follow-up ECD-SPECT, blood flow had increased slightly in the left forebrain and striatum, while it had decreased slightly in the thalamus. This suggests that the cause of hemichorea was related to ischemia. When the activity of the pallidum is impaired, it is presumed that the inhibitory activity towards the thalamus weakens and the thalamic cells become over-excited, causing chorea.
Copyright © 2015. Published by Elsevier Taiwan.

Entities:  

Keywords:  ECD-SPECT; cerebral infarction; diabetes mellitus; hemichorea; regional cerebral blood flow

Mesh:

Year:  2015        PMID: 25747012     DOI: 10.1016/j.jcma.2013.12.004

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  1 in total

Review 1.  "Diabetic striatopathy": clinical presentations, controversy, pathogenesis, treatments, and outcomes.

Authors:  Choon-Bing Chua; Cheuk-Kwan Sun; Chih-Wei Hsu; Yi-Cheng Tai; Chih-Yu Liang; I-Ting Tsai
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.